Detailed Introduction of [Ceclor] Cefaclor Extended-Release Tablets (II) 0.375g*4 Tablets

Overview

Product Name: Ceclor Cefaclor Extended-Release Tablets (II) 0.375g*4 Tablets

Cefaclor Extended-Release Tablets are specifically formulated for the treatment of infections caused by a wide range of susceptible pathogens. These infections include, but are not limited to, acute and chronic bronchitis, pharyngitis, tonsillitis, pneumonia, sinusitis, uncomplicated lower urinary tract infections, and skin and skin structure infections. The tablets, with each containing 0.375 grams of Cefaclor, offer a sustained-release mechanism for effective and convenient treatment.

Detailed Indications and Mechanism of Action

Mechanism of Action

Cefaclor belongs to the second-generation cephalosporin class of antibiotics. It exerts its antibacterial action by inhibiting the synthesis of bacterial cell walls, thereby disrupting the structural the bacteria and leading to their elimination. Cefaclor's activity spans a broad spectrum of both gram-positive and gram-negative organisms, making it a versatile treatment option for various infectious conditions.

Target Pathogens

• Gram-Positive Organisms:

• Streptococcus pneumoniae

• Streptococcus pyogenes

• Staphylococcus aureus (including methicillin-sensitive strains)

• Staphylococcus epidermidis

• Gram-Negative Organisms:

• Haemophilus influenz - Haemophilus parainfluenzae

• Moraxella catarrhalis

• Escherichia coli

• Klebsiella pneumoniae

• Proteus mirabilis

Spectrum of Activity

Cefaclor demonstrates broad-spectrum activity against both common and less common strains of the aforementioned pathogens, including those producing β-lactamases. This extensive coverage ensures that Cefaclor Extended-Release Tablets can be effectively utilized in treating a diverse range of infections.

Clinical Considerations

Dosage and Administration

The recommended dosage of Cefaclor Extended-Release Tablets should be individualized based on the patient's age, weight, renal function, and the severity of the infection. It is crucial to adhere to the prescribing information provided and adjust the dosage accordingly to ensure optimal therapeutic outcomes and minimize potential adverse effects.

Drug Interactions

Cefaclor, like other cephalosporins, may interact with specific medications. For instance, concurrent use with probenecid can increase Cefaclor's. Therefore, when administering Cefaclor in conjunction with other antibiotics or medications, dose adjustments or close monitoring for adverse reactions may be necessary.

Contraindications

Cefaclor Extended-Release Tablets are contraindicated in patients with a known hypersensitivity to cephalosporins or any component of the formulation. Caution should be exercised in patients with a history of allergic reactions to penicillins or other antibiotics, as cross-reactivity may occur.

Adverse Reactions

Common adverse reactions associatedaclor use include gastrointestinal disturbances such as diarrhea, nausea, and vomiting. Hypersensitivity reactions, such as rash and itching, may also occur. Less frequently, hepatic dysfunction or hematological abnormalities may be observed. Any signs of an allergic reaction or severe adverse effects necessitate immediate medical attention.